Journal of the American College of Cardiology 2013-06-18

Cardiohepatic interactions in heart failure: an overview and clinical implications.

Marc D Samsky, Chetan B Patel, Tracy A DeWald, Alastair D Smith, G Michael Felker, Joseph G Rogers, Adrian F Hernandez

Index: J. Am. Coll. Cardiol. 61(24) , 2397-405, (2013)

Full Text: HTML

Abstract

Heart failure (HF) is a major public health problem leading to frequent hospitalizations, impaired quality of life, and shortened life expectancy. Heart failure leads to a chronic inability to meet metabolic requirements of end organs or skeletal muscle. Current literature lacks comprehensive descriptions of HF effects on hepatic function. In this review paper, we summarize the literature that is available in hopes of highlighting the key differences in clinical presentation, histological findings, and biochemical profiles of patients who present with both acute and chronic liver injury secondary to HF. We further discuss the use of liver function tests as prognostic markers in patients with HF, as well as the implications of liver injury on drug metabolism in this patient population. Finally, we provide recommendations regarding the management of both types of liver injury in HF patients.Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Related Compounds

Related Articles:

Inhibition of human γ-glutamyl transpeptidase: development of more potent, physiologically relevant, uncompetitive inhibitors.

2013-03-15

[Biochem. J. 450(3) , 547-57, (2013)]

Pancreatic complications in pediatric choledochal cysts.

2013-09-01

[J. Pediatr. Surg. 48(9) , 1897-902, (2013)]

Low resolution X-ray structure of γ-glutamyltranspeptidase from Bacillus licheniformis: opened active site cleft and a cluster of acid residues potentially involved in the recognition of a metal ion.

2014-09-01

[Biochim. Biophys. Acta 1844(9) , 1523-9, (2014)]

The undernourished neonatal mouse metabolome reveals evidence of liver and biliary dysfunction, inflammation, and oxidative stress.

2014-03-01

[J. Nutr. 144(3) , 273-81, (2014)]

A new class of NO-donor pro-drugs triggered by γ-glutamyl transpeptidase with potential for reno-selective vasodilatation.

2013-02-18

[Chem. Commun. (Camb.) 49(14) , 1389-91, (2013)]

More Articles...